M-gCBT for Women With Provoked Localized Vulvodynia

Yalnız qeydiyyatdan keçmiş istifadəçilər məqalələri tərcümə edə bilərlər

Giriş / Qeydiyyatdan keçin

Bağlantı panoya saxlanılır

StatusTamamlandı

Sponsorlar

Oregon Health and Science University

Əməkdaşlar

Medical Research Foundation, Oregon

KLINIK SINAQ: NCT02919813

BioSeek: nct02919813

Açar sözlər

Mücərrəd

The purpose of this study is to learn more about Mindfulness based Group Cognitive Behavior Therapy (M-gCBT) as a treatment for Provoked Localized Vulvodynia (PLV). M-gCBT is a counseling technique that has been shown to reduce pain and anxiety with other medical conditions, including chronic pain conditions. The investigators wish to see if participation in M-gCBT course will help reduce anxiety, fear, and pain in women with PLV greater than education alone. Both techniques use a group setting including other women with PLV. "Mindfulness-Based Group Cognitive Behavior Therapy for Women with Localized Vulvodynia" is a study designed to learn more about the use of mindfulness based group cognitive behavior therapy for PLV pain and anxiety over education alone. Participants will be randomized to one of two groups: mindfulness based cognitive behavior therapy or group education seminars.

Təsvir

M-gCBT is a type of counseling that teaches women to have more control over their pain. Educational seminars teach women about the different aspects of PLV that affect emotional and physical health. Both groups will be given a binder containing course material at the first session and homework at each session that you will be asked to complete. The group education seminars will include an informational video clip reviewing an aspect of PLV and sexuality and will be followed by a group discussion facilitated by an instructor. Each session will involve a teacher and a small group of 6 to 12 women with PLV. Additionally, women in both groups will be asked to perform a weekly test to measure pain and to complete a daily diary.

Tarixlər

Son Doğrulandı:	11/30/2019
İlk təqdim:	07/18/2016
Təxmini qeydiyyat təqdim edildi:	09/26/2016
İlk Göndərmə:	09/28/2016
Son Yeniləmə Göndərildi:	12/08/2019
Son Yeniləmə Göndərildi:	12/29/2019
İlk təqdim edilmiş nəticələrin tarixi:	11/11/2019
İlk təqdim edilmiş QC nəticələrinin tarixi:	12/08/2019
İlk göndərilən nəticələrin tarixi:	12/29/2019
Həqiqi Təhsilin Başlama Tarixi:	12/15/2015
Təxmini İlkin Tamamlanma Tarixi:	09/29/2017
Təxmini İşin Tamamlanma Tarixi:	09/29/2017

Vəziyyət və ya xəstəlik

Provoked Localized Vulvodynia

Müdaxilə / müalicə

Behavioral: M-gCBT Group

Behavioral: Educational Seminars

Faza

Qol Qrupları

Qol	Müdaxilə / müalicə
Active Comparator: M-gCBT Group Mindfulness Based Group Cognitive Behavior Therapy (M-gCBT Group) is a type of counseling that teaches women to have more control over their pain.	Behavioral: M-gCBT Group Mindfulness Based Group Cognitive Behavior Therapy is a type of counseling that teaches women to have more control over their pain.
Active Comparator: Educational Seminars Educational seminars teach women about the different aspects of PLV that affect emotional and physical health.	Behavioral: Educational Seminars Educational seminars teach women about the different aspects of PLV that affect emotional and physical health.

Uyğunluq Kriteriyaları

Təhsil üçün uyğun yaşlar	18 Years Üçün 18 Years
Təhsilə Uyğun Cinslər	Female
Sağlam Könüllüləri qəbul edir	Bəli
Kriteriyalar	Inclusion Criteria: 1. Reported dyspareunia for at least 6 months in non-pregnant, healthy women over aged 18-45 years old meeting Friedrich's criteria for PLV.51 2. Qtip Test51-52, 54 mean verbal rating score of ≥4/10 in 4 of 6 defined points of the vestibule (2, 4, 6, 8, 10, 12 o'clock), and have received a Qtip Test score of verbal ≤ 2/10 for the labia majora and minora, intra labial sulcus, and perineum. 3. Ability to insert a regular Tampax® tampon 4. Baseline tampon test pain score ≥80mm 5. Phone access 6. Lives within 60 miles with reliable transportation Exclusion Criteria: 1. Pregnancy 2. Active counseling or mindfulness training (within 6 months of study) 3. Any other clinical reason for dyspareunia (endometriosis pain, chronic pelvic pain, vulvar dermatoses such as psoriasis, lichen sclerosus, etc). 4. Impaired cognition or disruptive behavior not conducive to group dynamic 5. Planned long term travel or surgery during study period 6. Unable or unwilling to complete baseline assessments or agree to be randomized. 7. Axis 2 diagnosis, chronic substance abuse, suicidality or disruptive to group dynamic 8. Non-English speaking

Nəticə

İlkin nəticə tədbirləri

1. Tampon Test [Change from time of enrollment until 6 months after study]

The change from baseline in pain measured by the Tampon Test at 6 months. The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon. Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine). This test will occur at baseline and 6 months follow up.

İkincili Nəticə Tədbirləri

1. Sexual Distress Survey Response [Change from time of enrollment until 6 months after study]

Change from baseline in sexual distress at 6 months. Participants will complete a Female Sexual Distress Scale (FSDS) survey to rate their feelings associated with sexual activities; range 0 (better outcome) - 52 (worse outcome). The FSDS surveys will be completed at baseline and 6 months follow up. A negative change in FSDS score from baseline indicates less sexual distress over time (better outcome) and a positive change in FSDS score from baseline indicates more sexual distress over time (worse outcome).

2. Sexual Function Questionnaire Response [Change from time of enrollment until 6 months after study]

Change from baseline in sexual function at 6 months. Participants will complete a Female Sexual Function Index (FSFI) survey which asks questions about participants sexual feelings over the past 4 weeks; range 2 (worse outcome) - 95 (better outcome). The FSFI surveys will be completed at baseline and 6 months follow up. A negative change in FSFI score from baseline indicates less sexual function over time (worse outcome) and a positive change in FSFI score from baseline indicates more sexual function over time (better outcome).

3. Depression Questionnaire Response [Change from time of enrollment until 6 months after study]

Change from baseline in depression at 6 months. Participants will complete the Beck Depression Inventory (BDI-PC) questionnaire, which consists of 21 groups of statements where participants selects which statement best describes how they have been feeling during the past 2 weeks. Total score = sum of 21 statement subscales; range 0 (better outcome) - 63 (worse outcome). The BDI-PC surveys will be completed at baseline and 6 months follow up. A negative change in BDI-PC score from baseline indicates less depression over time (better outcome) and a positive change in BDI-PC score from baseline indicates more depression over time (worse outcome).

4. Anxiety Questionnaire Response [Change from time of enrollment until 6 months after study]

Change from baseline in anxiety at 6 months. Participants will complete the General Anxiety Disorder-7 (GAD-7) scale questionnaire. The GAD-7 consists of 7 problems where participants rate how often they have been bothered by those problems during the past 2 weeks. Total score = sum of 7 subscales; range 0 (better outcome) - 21 (worse outcome). The GAD-7 surveys will be completed at baseline and 6 months follow up. A negative change in GAD-7 score from baseline indicates less anxiety over time (better outcome) and a positive change in GAD-7 score from baseline indicates more anxiety over time (worse outcome).

5. Pain Catastrophizing Scale Response [Change from time of enrollment until 6 months after study]

Change from baseline in pain catastrophizing at 6 months. Participants will complete the Pain Catastrophizing Scale survey. The survey consists of thirteen statements describing different thoughts and feelings that may be associated with pain. Total score = sum of 13 statement subscales; range 0 (better outcome) - 52 (worse outcome). The pain catastrophizing surveys will be completed at baseline and 6 months follow up. A negative change in score from baseline indicates less pain catastrophizing over time (better outcome) and a positive change in score from baseline indicates more pain catastrophizing over time (worse outcome).

6. Quality of Life Questionnaire Response [Change from end of study until 6 months after study]

Perceived treatment improvement and satisfaction in quality of life questionnaire. Questionnaires for quality of life at end of group intervention and at 3 months and 6 months follow up.